| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/29/2009 | CN101416995A Epimedium extract and preparation method, preparation and use thereof |
| 04/29/2009 | CN101416993A Traditional Chinese medicine composite preparation for treating angina pectoris made by notoginseng, ixeri sonhifolia extract |
| 04/29/2009 | CN101416992A Beggarticks dispersion tablets and preparation method thereof |
| 04/29/2009 | CN101416991A Traditional Chinese medicine preparation for treating cerebrovascular disease and preparation technique thereof |
| 04/29/2009 | CN101416990A Jasmine flower extract and preparation method and use thereof |
| 04/29/2009 | CN101416989A Extraction method of antihypertensive active substance in red rice and red rice antihypertensive medicine |
| 04/29/2009 | CN101416972A External medicine capable of preventing and treating cardiovascular disease and preparation method thereof |
| 04/29/2009 | CN101416966A Medical composition capable of treating hypertension |
| 04/29/2009 | CN101416965A Oral nifedipine slow-release preparation and preparation method thereof |
| 04/29/2009 | CN101416964A Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus |
| 04/29/2009 | CN101416963A Nimodipine freeze-drying sub micellar emulsion for injection and preparation method thereof |
| 04/29/2009 | CN101416954A Nitrendipine self-emulsification soft capsules and preparation method thereof |
| 04/29/2009 | CN101416951A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416950A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416944A Sodium ferulic acid nano micelle preparation and preparation method thereof |
| 04/29/2009 | CN101416942A Nimodipine sub micro-emulsion injection and preparation method thereof |
| 04/29/2009 | CN101416939A Puerarin liquid formulation and preparation method thereof |
| 04/29/2009 | CN101416731A Hawthorn beverage and preparation method thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482251C Chinese medicinal formulation for curing hypertension by treating disease cause |
| 04/29/2009 | CN100482244C Compound recipe medicine for treating apoplexy and its preparation method |
| 04/29/2009 | CN100482235C 2-glucoside Chinese medicinal oral preparation and its making method thereof |
| 04/29/2009 | CN100482234C Stibene-glucoside oral liquid and its production method |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482223C 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors |
| 04/29/2009 | CN100482220C Oral preparation of bilobalide with high bioavailability and preparation method thereof |
| 04/29/2009 | CN100482218C Application of Danshensu in preparation of medicine for treating cerebrovascular diseases |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482129C Health care medicated pillow |
| 04/28/2009 | US7524975 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524936 labeled monoclonal or polyclonal antibodies that preferentially binds oxidoreductase enzyme polypeptides, proteins, fragments, domain peptides or amino acid sequences having replacements, capable of superoxide production |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524817 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 04/28/2009 | US7524679 Methods for culturing human lung mast cells and uses thereof |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | CA2562251C Pyrazolo'4,3-d pyrimidines |
| 04/28/2009 | CA2555258C 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity |
| 04/28/2009 | CA2507465C Phenyl substituted piperidine compounds for use as ppar activators |
| 04/28/2009 | CA2472954C Aza-arylpiperazines |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2400176C Substituted piperazine compounds |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2336783C Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 04/23/2009 | WO2009052478A1 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009051666A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050580A1 Composition for regulating lipid metabolism |
| 04/23/2009 | WO2009050318A1 Pyrazole derivatives of fatty acid amides as ppar-alpha receptor specific activators, preparation method thereof and use of same |
| 04/23/2009 | WO2009050253A1 Trisubstituted piperidines |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | WO2009049914A2 Novel patient subgroups for thrombolysis |
| 04/23/2009 | WO2009049742A2 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 04/23/2009 | WO2009049495A1 Crystalline imidazol-5-carboxylic acid derivate |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | WO2009049362A1 A1 adenosine receptor allosteric enhancers |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2008133896A3 Dual-acting antihypertensive agents |
| 04/23/2009 | WO2008065485A3 Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor |
| 04/23/2009 | US20090105687 Scoring catheter with drug delivery membrane |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105328 Amino Acid Compounds |
| 04/23/2009 | US20090105322 Pharmaceutical composition comprising valsartan |
| 04/23/2009 | US20090105317 VEGF Inhibition |
| 04/23/2009 | US20090105314 Pharmaceutical Agent |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105251 Renin inhibitors |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105220 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 04/23/2009 | US20090105208 Substituted Piperazines as CB1 Antagonists |
| 04/23/2009 | US20090105205 Methods of treating disease states using antiangiogenic agents |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105181 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 04/23/2009 | US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury |
| 04/23/2009 | US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105148 Compositions and methods for treating myocardial infarction |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104262 Chlorthalidone combinations |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104246 local administration of a combination of rapamycin and panzem for the treatment of vulnerable plaque |
| 04/23/2009 | US20090104240 Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104211 Treatment of atherosclerosis |